Discussant for SENOMAC (GS02-06), NSABP B-51/RTOG 1304 (GS02-07), and IDEA (GS02-08) ( AXILECTOMIA VERSUS RADIOTERAPIA )
Prospective WSG phase III PlanB trial: Final analysis of adjuvant 4xEC→4x doc vs. 6x docetaxel/cyclophosphamide in patients with high clinical risk and intermediate-to-high genomic risk HER2-negative, early breast cancer
Comentários
Postar um comentário